NCT02947386 2023-10-05Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung CancerRoswell Park Cancer InstitutePhase 1 Completed7 enrolled
NCT00985998 2015-08-19Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung CancerBiotech Pharmaceutical Co., Ltd.Phase 1 Withdrawn